Growth and metastasis of malignant tumors requires angiogenesis. Inhibition of tumor -induced angiogenesis may represent an effective cytostatic strategy. We have constructed recombinant self -inactivating lentiviral vectors expressing angiostatin and endostatin, and have tested their antiangiogenic activities. As VSV -G -pseudotyped lentiviral vectors showed low relative transduction titers on bovine aortic and human umbilical vein endothelial cells, it was difficult to achieve significant inhibition of endothelial cell growth by lentivirus -mediated antiangiogenic gene transfer directly to endothelial cells without concomitant vector -associated cytotoxicity. However, lentivirus vectors could efficiently and stably transduce T24 human bladder cancer cells that are relatively resistant to adenovirus infection due to loss of coxsackievirus -adenovirus receptor expression. Long -term expression and secretion of angiostatin and endostatin from lentivirus -transduced T24 cells resulted in significant inhibition of cellular proliferation on coculture with endothelial cells. This report represents the first use of lentivirus -based vectors to deliver the antiangiogenic factors, angiostatin and endostatin, and suggests the potential utility of antiangiogenic gene therapy with lentiviral vectors for the treatment of cancer. Cancer Gene Therapy ( 2001 ) 8, 879 -889 
A ngiogenesis, the proliferation of new blood vessels, is essential for tumor growth and metastasis. 1 The angiogenic phenotype is considered to be the result of a net balance between these positive and negative regulators. To stimulate angiogenesis, tumors may up -regulate the secretion of a variety of growth factors including basic fibroblast growth factor (bFGF ) 2 and vascular endothelial cell growth factor ( VEGF ), 3 which stimulate endothelial cell proliferation and migration. Malignant tumors may also decrease expression of endogenous inhibitors of angiogenesis, including thrombospondin, 4 angiostatin, 5 and endostatin. 6 Angiostatin is an internal fragment of plasminogen comprising the first four kringle domains, first isolated from the serum and urine of mice bearing Lewis lung carcinoma. 5 Endostatin is the carboxyl terminal fragment of collagen XVIII, first purified from conditioned media obtained from the EOMA murine hemangioendothelioma cell line. 6 Both have recently been shown to inhibit endothelial cell proliferation in vitro and to suppress established and metastatic tumor growth in animal models. 5 -9 However, peptide-based therapeutic strategies using these antiangiogenic factors have encountered significant difficulties with large-scale protein production, short circulating half -life and low peptide stability in vivo, and long -term administration to maintain tumor suppression. 8, 10, 11 Delivery of the genes encoding these angiogenic inhibitors using viral vectors may represent a more effective strategy that has the potential for in situ production of higher local concentrations of these inhibitors than those achieved by systemic infusion of antiangiogenic peptides, and this will more efficiently prevent the induction of new blood vessel formation as well as minimize potential systemic side effects. However, as antiangiogenic therapy is cytostatic and small nests of tumor cells can still survive in the absence of angiogenesis, an efficient gene delivery system that achieves stable long -term expression of the peptides is necessary for this approach to be successful. Previously, adenovirus and adeno-associated virus (AAV ) vectors have been used to deliver angiostatin 12 -14 and endostatin, 14 -17 but adenovirus results in only transient expression and it is often difficult to obtain high titers of AAV.
Lentiviruses represent an attractive new vector system that allows permanent integration of the delivered transgene and can be pseudotyped with a variety of envelopes to achieve broad tropism. 18 -22 To date, there has been one report describing lentivirus -mediated gene delivery of a noncatalytic fragment of matrix metalloproteinase -2 that resulted in inhibition of tumor angiogenesis, 23 but, hitherto, there have been no previous reports of lentivirus -based vectors expressing direct inhibitors of endothelial cell growth. Accordingly, we have developed recombinant lentivirus vectors for long -term expression of angiostatin and endostatin, and the functionality of these vectors was compared with that of adenoviral vectors encoding the same transgenes, for achieving either autocrine growth inhibition by gene transfer directly to endothelial cells, or paracrine growth inhibition of cocultured endothelial cells after gene transfer to cancer cells.
MATERIALS AND METHODS

Cell lines
Bovine aortic endothelial cells ( BAEC; provided by M. Yokoyama, Kobe University School of Medicine, Kobe, Japan ) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 15% fetal bovine serum ( FBS ) and 1% penicillin -streptomycin (P /S ) . Human umbilical vein endothelial cells ( HUV-EC -C; ATCC# CRL -1730; American Type Culture Collection ( ATCC ) , Rockville, MD ) were maintained in EBM -2 basal media or EGM -2 growth factor-supplemented media ( BioWhittaker, Walkersville, MD ) with 10% FBS. The human bladder cancer cell line T24 ( ATCC, #HTB -4) and cervical cancer cell line HeLa (ATCC, #CCL -2) were maintained in DMEM supplemented with 10% FBS and 1% P /S. All cells were incubated at 378C in a humidified incubator with 5% CO 2 .
Recombinant lentivirus and adenovirus vector construction
Lentivirus vector encoding angiostatin. To generate the parental control vector, the BamHI /SalI fragment of MND -X -IRES-EGFP 24 (kindly provided by D. B. Kohn, Children's Hospital Los Angeles, CA ) , which contains the internal ribosome entry site (IRES ) from encephalomyocarditis virus and the Aequorea green fluorescent protein ( GFP ) coding sequence, was cloned into a human immunodeficiency virus -1 (HIV-1 ) -based self -inactivating lentivirus vector, pRRLsinhCMVGFP, 22 replacing the existing GFP sequence. The resultant vector plasmid, pSin -GFP, was used as a control. The coding sequence of murine angiostatin was amplified by polymerase chain reaction ( PCR ) from plasmid pPICZ -Angiostatin, generously provided by J. Folkman (Children's Hospital, Boston, MA ) . The sequence encoding 39 amino acids spanning the signal peptide of thrombospondin -1 ( SPhTHBS -1) was also amplified by PCR using the human thrombospondin -1 ( THBS -1 ) cDNA (kindly provided by D. Roberts, NIH, Bethesda, MD ) as a template. The two PCR products, angiostatin digested with RsrII /EcoRI and SPhTHBS -1 digested with BamHI /RsrII, were cloned together in frame into pSin -GFP (Fig 1A ) . The resulting vector plasmid pSinAng was used to generate the recombinant lentivirus Sin -Ang.
Adenovirus vector encoding angiostatin. A recombinant adenovirus vector encoding angiostatin was generated by a simplified system using homologous recombination in bacteria 25 (generously provided by B. Vogelstein, Johns Hopkins, Baltimore, MD ) . Briefly, the BamHI / SalI fragment of pSin -Ang was cloned into a shuttle vector, pShuttle -CMV. 25 The resulting recombinant adenovirus plasmid, pAd -Ang was constructed by cotransformation with the backbone plasmid pAdEasy -1, into the recombinogenic E. coli strain BJ5183 (Fig 1C ) .
Lentivirus vector encoding endostatin. The murine endostatin coding sequence was amplified by PCR using the plasmid pBacPAK8 -endostatin 6 (also provided by J. Folkman ) as a template. The sequence spanning the signal peptide of THBS-1 was again amplified by PCR, and as above, the two sequences were joined in frame by overlap -extension PCR, and the resultant product was cloned into pSin -GFP ( Fig 1A ) . The resulting vector plasmid pSin -End was used to generate the recombinant lentivirus Sin -End.
Adenovirus vector encoding endostatin. To generate recombinant adenovirus encoding endostatin, the BamHI /SalI fragment of pSin -End was cloned into pShuttle -CMV. The resulting recombinant adenovirus plasmid, pAd -End was also constructed by bacterial homologous recombination as described above ( Fig 1C ) .
To ensure the integrity of the plasmid constructs, all coding sequences generated by PCR, and the regions surrounding the ligation joints in each adenovirus and lentivirus construct were confirmed by fluorescent dideoxynucleotide sequencing with an ABI sequencer (PerkinElmer Applied Biosystems, Foster City, CA ) by the USC Microchemical Core Facility.
Production of viral vectors
Lentivirus vectors. Lentivirus vectors were produced using a transient cotransfection system as described previously. 19 Briefly, approximately 1Â10 7 293T cells were transfected with 7.5 g of the envelope plasmid pMD.G encoding the G glycoprotein of vesicular stomatitis virus ( VSV-G ) , and 15 g each of the packaging plasmid, pCMVÁR8.91, 21 and one of the various vector plasmids. Three harvests of conditioned media containing recombinant lentivirus were collected 48-72 hours later and concentrated by ultracentrifugation. For some experiments, 15 g of envelope plasmid pCAE encoding the amphotropic 4070A murine leukemia virus ( MLV ) envelope (kindly provided by Dr. W. French Anderson, USC ) was used instead of VSV-G for pseudotyping.
Adenovirus vectors. To propagate the recombinant adenovirus vectors Ad -GFP, Ad -Ang, and Ad -End, a standard amplification protocol was used to obtain high -titer viral stocks. Briefly, 1Â10 5 293A cells (Quantum Biotechnologies, Montreal, Canada ) were transfected with linearized recombinant adenovirus plasmid using Lipofectamine (Life Technologies, Gaithersburg, MA ) . Ten days after transfection, virus was initially harvested by multiple freezethaw cycles of 293A cell lysates, and by pelleting the cell debris to obtain a crude virus preparation. Virus preparations were further amplified by serial passage on progressively larger scale 293A cell cultures to obtain high -titer virus stocks, and purified by double cesium gradient ultracentrifugation followed by dialysis.
Retrovirus vectors. For some experiments, standard MLVbased retrovirus vectors were also produced by transient cotransfection as above, using 15 g of the packaging plasmid pCGP that encodes a CMV-driven MLV gag-pol expression cassette ( kindly provided by Dr. Paula Cannon, USC ), 15 g of the vector plasmid pMLV-GFP that encodes a GFP reporter transgene driven by the MLV long terminal repeat (LTR ) promoter, and either 7.5 g of the envelope plasmid pMD.G encoding VSV-G or 15 g of pCAE encoding amphotropic MLV envelope. Conditioned media containing recombinant retrovirus was collected and concentrated as above.
Vector titration and determination of relative transduction efficiencies
Reference titers were determined on HeLa cells by fluorescence -activated cell sorter ( FACS ) analysis for GFP expression using a FACScan (Becton Dickinson, San 5 HeLa cells were plated in six -well clusters ( Corning, Corning, NY ) and infected with serial 10 -fold dilutions of viral vectors ( 10 À 1 to 10 À 5 ) in a 2 -mL volume of culture medium. In the case of lentiviral vectors, 8 g /mL polybrene (Sigma, St. Louis, MO ) was added to the culture media. The actual cell number at the time of infection was determined by trypsinizing and counting uninfected wells that had been plated in parallel. Cells were collected 72 hours after infection and the number of GFP -positive cells in the linear range of FACScan detection was used to quantify the titer, according to the following formula: Transduction units per milliliter ( TU / mL ) = (cell number at the time of infection )Â ( percentage of GFP positive cells) Â (dilution factor). In the case of adenovirus vectors, polybrene was not added to the medium. Titers of adenovirus preparations were also determined by the TCID 50 method, which utilizes 293 cells as the reference cell type for titration by detection of cytopathic effects.
To assess the relative infectivity of lentivirus and adenovirus vectors on the several types of cells used for these experiments, 2Â10
5 cells of HeLa, T24, BAEC, and HUV-EC -C cells were infected with serial dilutions of the Sin -GFP or Ad -GFP vector preparations, and the respective titers were determined 72 hours later by FACS analysis as above.
Sodium dodecyl sulfate -polyacrylamide gel electrophoresis ( SDS -PAGE ) and Western blotting
To confirm the production and secretion of peptides after lentivirus infection, T24 cells infected with Sin -Ang ( T24Ang ) , Sin -End ( T24End) , or Sin -GFP (T24 GFP ) at multiplicities of infection (MOIs ) = 5 were plated on 60 -mm dishes at a density of 2Â10 6 per dish and incubated for 48 hours in serum -free medium. For adenovirus infections, 2Â10 6 HeLa cells were infected with Ad -Ang, Ad -End, or Ad -GFP at MOI =100 and incubated for 48 hours in serum free medium. The conditioned media were collected and concentrated 10-fold with a Microcon-10 column ( Millipore, Bedford, MA ), 10 L of each sample was subjected to SDS -PAGE using 4 -20% linear gradient gels (Bio -Rad, Hercules, CA ), and proteins were transferred to nitrocellulose membranes (Pall Gelman Sciences, Ann Arbor, MI ) . For Western blotting, goat anti -human angiostatin ( 1:500 ) or goat anti -mouse endostatin (1:1000 ) ( R&D Systems, Minneapolis, MN ) were used as the primary antibodies and peroxidase-conjugated swine antigoat antibody (1:3000 ) ( CalTag, Burlingame, CA ) was used as the secondary antibody. Chemiluminescent detection of bound antibodies was performed using the ECL system ( Amersham Pharmacia Biotech, Piscataway, NJ ).
Proliferation assays Colorimetric assay. BAEC or HUV-EC -C cells ( 5Â10 3 cells/well) were seeded into 96-well plates 24 hours before treatment. The cells were infected by increasing MOI of recombinant lentivirus and adenovirus vectors in 100 L of culture medium with bFGF ( 1 ng/ mL ) . For lentivirus infections, polybrene was added to the culture medium at a final concentration of 8 g /mL. Seventy -two hours after treatment, cells were quantified with a colorimetric tetrazolium -based cell proliferation assay kit (CellTiter 96 Aqueous, Promega, Madison, WI ) .
Coculture assay. T24Ang, T24End, and T24GFP cells (2Â10 5 ) were seeded on Transwell chambers with a 0.4 -m pore -size ( Corning Costar, Cambridge, MA ) . BAEC cells (1Â10 5 ) were plated on six -well culture plates with the appropriate culture medium. The Transwell chambers were then assembled on the six -well plates for coculture 24 hours later. After 48 hours, bFGF (1 ng /mL ) was added to the media. After stimulation with bFGF, BAEC cells were collected by trypsinization 48 hours later, counted, washed with PBS, then fixed with 1 mL of 70% ethanol and kept at 48C for cell cycle analysis.
Cell cycle analysis
Cell samples fixed in 70% ethanol were resuspended with 1 mL of PBS containing 50 g /mL propidium iodide and 100 U / mL Rnase A, and incubated for 90 minutes. The DNA content of each sample was measured with an EPICS Profile Analyzer ( Beckman Coulter, Fullerton, CA ) . The percentages of each phase of the cell cycle were calculated by Multicycle software (Phoenix Flow Systems, San Diego, CA ).
Statistical analysis
All experiments were independently performed at least three times. The results are presented as mean ± standard deviation. Statistical significance of differences was calculated using Student's t test.
RESULTS
Production and secretion of antiangiogenic peptides from lentivirus vectors
Production of secreted forms of murine angiostatin and endostatin after gene transfer by vesicular stomatitis virus G protein ( VSV-G ) -pseudotyped self -inactivating lentivirus vectors Sin -Ang and Sin -End, respectively, was confirmed by Western blot of conditioned medium from transduced cells ( Fig 1B ) . As the coding sequences of angiostatin and endostatin represent, respectively, internal and carboxyterminal fragments of the larger proteins plasminogen 5 and collagen XVIII, 6 these sequences alone are not sufficient for efficient translation and secretion in mammalian cells; therefore, the signal peptide of human thrombospondin -1 ( SPhTHBS-1) was fused in -frame to the 5 0 ends of each coding sequence (Fig 1A ) , and a stop codon was appended to the end of the angiostatin coding sequence. Sin -GFP, a vector containing only the CMV-IRES -GFP expression cassette without any transgene upstream of the IRES, was used as a negative control.
As expected, both angiostatin and endostatin were observed to be secreted into the cell culture medium after transduction by their respective vectors, and each peptide was recognized by specific antibodies ( Fig 1B ) . It should be noted that, although angiostatin is a 357 -amino-acid peptide with a predicted molecular mass of $38 kDa, the observed molecular mass of murine angiostatin after expression in mammalian cells was about M r $70 kDa, presumably due to the presence of two glycosylation sites as previously reported. 11, 12 Murine endostatin, with a mature peptide sequence of 184 amino acids, was detected as an M r $20 -kDa band as predicted.
As vector controls, recombinant adenoviruses expressing the secreted forms of angiostatin and endostatin, designated Ad -Ang and Ad -End, respectively, were also constructed and produced ( Fig 1C ) . As above, a negative control vector, designated Ad -GFP, was also constructed and produced containing only the CMV-GFP expression cassette. Antiangiogenic peptide expression and secretion from Ad -Ang and Ad -End was also confirmed by Western blot of conditioned medium from transduced cells as above (Fig 1D) .
Relative transduction efficiencies of lentivirus, adenovirus, and retrovirus vectors
To allow precise quantitation of titer and transduction efficiency, FACS analysis was used to detect gene transfer and expression of the GFP marker. Using this method, titers of unconcentrated vector harvests were generally determined to be on the order of 10 6 TU /mL, and further concentration by ultracentrifugation generally yielded titers on the order of 10 7 to 10 8 TU / mL on a reference population of HeLa cells ( Table 1 and data not shown) .
Antiangiogenesis can be achieved either by gene delivery to cancer cells, which would then express and secrete angioinhibitory factors that prevent proliferation of adjacent endothelial cells in a paracrine mode, or by direct transduction of endothelial cells, which would result in an autocrine mode of inhibition. To test the applicability of lentivirus vectors for either approach, the relative transduction efficiencies of VSV-G -pseudotyped lentiviral vectors were tested on a number of target cell types, including HeLa (human cervical carcinoma ) , T24 (human bladder carcinoma ), BAEC ( primary bovine aortic endothelial cells ), and HUV-EC -C ( primary human umbilical vein endothelial cells), by FACS analysis as above. Our results show that lentivirus vectors are capable of efficient gene transfer to both HeLa and T24 cancer cells, exhibiting transduction titers of approximately 10 7 TU /mL for both cell lines with the use of concentrated vector preparations ( Table 1) . However, there appeared to be a relative block to lentivirus -mediated transduction of both BAEC and HUV-EC -C endothelial cells, resulting in up to 100 -fold titer reduction compared to titers of the same vector preparation on the cancer cell lines (Fig 2A ) . In comparison, the titers of cesium -purified adenovirus preparations were generally one to two orders of magnitude higher than those of lentivirus vector preparations when titered by the TCID 50 method using 293 cells as the reference cell line (i.e., on the order of 10 9 infectious units per milliliter; data not shown ) or when titered by FACS using HeLa cells as the reference cell line ( i.e., on the order of 10 8 TU /mL; Table 1 ). However, when relative gene transfer efficiency was assessed, these endothelial cell lines were again found to be approximately up to 100 -fold more resistant to transduction compared to HeLa cells ( Fig 2B ) . Moreover, T24 cells, which are known to have lost expression of the coxsackievirus -adenovirus receptor (CAR ) , 26 were equally difficult to transduce. One potential advantage of lentivirus vectors compared to standard MLV-based retrovirus vectors is their ability to infect nondividing cells. Therefore, transduction efficiencies of lentivirus vectors pseudotyped with either VSV-G or amphotropic 4070A envelope were compared against those of the equivalent MLV retrovirus vectors. Transduction efficiencies were normalized against the reference titers on HeLa cells to adjust for differences in titer of individual vector preparations. As expected, lentivirus vectors showed no particular advantage when compared with standard MLV vectors on rapidly dividing cancer cell lines such as T24 ( data not shown ), but did exhibit approximately 10 -fold higher transduction efficiency on more slowly dividing endothelial cell lines such as HUV-EC -C (Table 2 ) .
Autocrine inhibition of endothelial cell growth by direct transduction with antiangiogenic vectors
As the transduction titers of lentivirus vectors on endothelial cells were significantly lower than those on HeLa or T24 cells, serially increasing MOIs were employed to test the effect of autocrine angiostatin and endostatin expression on cellular proliferation after direct infection of BAEC or HUV-EC -C cells. All MOIs were calculated according to the relative transduction titers of each vector for each individual cell type as above. A colorimetric assay was used to examine cellular proliferation over a period of 72 hours after transduction by Sin -GFP, Sin -Ang, or Sin -End. Transduction with Sin -Ang at MOI =0.2 showed a significant inhibitory effect on the proliferation of BAEC cells ( P <.001 ) compared to the Sin -GFP control vector ( Fig 3A ) . However, the significance of this effect was reduced at higher MOI, as even the Sin -GFP -transduced control group exhibited more than 50% inhibition of BAEC proliferation at MOI = 1 -5 compared to the uninfected Both lentivirus and MLV -based GFP expression vectors were pseudotyped with either VSV -G or amphotrophic 4070A ( ampho ) virus envelope, and used to infect 2Â10 5 HUV -EC -C cells cultured in EBM -2 basal media containing 0.5% FCS. Transduction titers were determined by FACScan for GFP expression 72 hours later. To account for differences in absolute titers between different vector preparations, the HUV -EC -C titer of each vector / envelope combination was normalized to its respective titer after infection of a reference population of HeLa cells. The values shown in bold thus represent comparative infectivity values, based on infectivity of HeLa cells as 100, and the fold difference of lentivirus over MLV vectors for each envelope pseudotype are shown in the far right column. controls, suggesting nonspecific toxicity of the vector itself. In contrast, HUV-EC -C cells appeared to be less sensitive to vector -associated toxicity, and no reduction in HUV-EC -C proliferation was observed in the Sin -GFP control group up to MOI =12.5 compared to the uninfected controls. However, further increases in lentivirus vector MOI above this level were again observed to result in vector-associated toxicity ( data not shown ). HUV-EC -C cells also appeared to be more refractory to the effects of Sin -Ang and Sin -End transduction, with a small but significant inhibitory effect observed only after Sin -End transduction at the highest well -tolerated MOI of 12.5 (P < .05, Figure 3B ) .
This vector-associated toxicity may be due to contamination of the vector preparation with excess amounts of soluble VSV-G protein, which is known to be highly fusogenic, produced during the transfection. To further assess this possibility, the effects of incubating lentivirus vector preparations on BAEC cells were compared against the effects of incubating conditioned medium that was harvested and concentrated using the same procedures, but after transfection of 293 cells with VSV-G envelope plasmid alone. The results, shown in Table 3 , demonstrate that conditioned medium from 293 cells expressing the VSV-G envelope plasmid alone results in a significant reduction in viability of BAEC cells of the same magnitude as that observed with VSV-G -pseudotyped lentivirus vector preparations, when compared to controls consisting of conditioned medium from mock -transfected cells. All incubations were performed in the presence of 8 g/mL polybrene; thus, nonspecific toxicity due to polybrene can be ruled out. As in the case of lentivirus vector preparations, this nonspecific toxicity was observed to diminish with increasing dilutions of the VSV-G conditioned medium, again supporting the presence of a soluble factor present in the supernatant medium of cells transfected with VSV-G alone ( Table 3) .
In contrast, there was no evidence of vector-associated toxicity after direct infection of BAEC or HUV-EC -C cells with Ad -GFP at any MOI tested, whereas direct infection of BAEC with Ad -Ang and Ad -End resulted in significant and dose -dependent inhibition of cellular proliferation ( Fig 3C ) . More than 80% inhibition could be achieved after direct transduction with increasing MOI of Ad -End ( P <.001 at MOI= 0.5 -2.5 ). A similar effect was noted with Ad -Ang, although inhibition was much more pronounced at MOI= 2.5 ( P <.001 ) than at MOI =0.5 ( P <.05). In comparison, the Ad -GFP control vector showed no effect on cellular proliferation of BAEC or HUV-EC -C cells at any MOI. Direct transduction by Ad -End achieved up to 50% inhibition of HUV-EC -C cell proliferation in a dosedependent manner, but only by employing much higher MOIs ( P <.05 at MOI= 20 -40, P < .001 at MOI= 100, Conditioned media containing lentivirus vector Sin -GFP produced by three -plasmid cotransfection as described in Materials and Methods ( lentivirus ) , or from 293T cells transfected only with 7.5 g of the VSV -G expression plasmid pMD.G ( VSV -G ) , or mock transfections using the same procedure ( mock ) , were each collected and concentrated in parallel by ultracentrifugation and resuspended in the same volume. BAEC cells ( 5Â10 3 cells / well ) were exposed to 1 / 10, 1 / 100, and 1 / 100 dilutions of each conditioned medium preparation in a total volume of 100 L DMEM containing final concentrations of 15% FBS and 8 g / mL polybrene, and cell proliferation was quantified 72 hours after treatment using the CellTiter 96 Aqueous colorimetric assay. Asterisks indicate significant P values compared to mock -transfected preparations; *P < .01.
Cancer Gene Therapy, Vol 8, No 11, 2001 SHICHINOHE, BOCHNER, MIZUTANI, ET AL: LENTIVIRUS-MEDIATED GENE DELIVERY Figure 3D ) . Inhibition by Ad -End was again stronger than Ad -Ang, which showed inhibitory effects only at the highest MOI tested (MOI= 100; P < .001) . The weaker inhibitory effect of Ad -Ang and Ad -End transduction on HUV-EC -C compared to BAEC, even though relative transduction titers of adenovirus are higher on HUV-EC -C than BAEC ( Fig 2B ) , again suggests that HUV-EC -C cells are more refractory than BAEC cells to the effects of angiostatin and endostatin.
Paracrine inhibition of endothelial cell growth by coculture with transduced cancer cells after lentivirus -mediated antiangiogenic gene transfer
As the VSV-G envelope is thought to bind to cell surface phospholipids, 27, 28 VSV-G -pseudotyped lentivirus vectors have a potential advantage over adenovirus serotype 5 -based vectors in their ability to achieve efficient gene delivery to cancer cells even if they lack specific cell surface proteins that normally act as receptors for virus entry. Furthermore, another advantage of lentivirus vectors is their potential to achieve stable integration and long -term expression of delivered transgenes. When T24 bladder cancer cells that had been pretransduced with Sin -Ang ( T24Ang ) , Sin -End (T24End) , or the Sin -GFP control lentivirus vector (T24GFP ) at MOI =5 were examined by flow cytometry to confirm the percentage of infected cells, typically > 80 -90% of transduced cells were found to be GFP -positive for more than 11 weeks without any evidence of vector-associated toxicity ( data not shown ). In contrast, adenoviral vectors were found to infect T24 cells inefficiently ( Fig 2B ) , and the percentage of cells expressing the transgenes dropped rapidly and steadily, becoming undetectable over a period of 11 days after transduction with adenovirus vectors ( data not shown ).
Lentivirus -mediated gene transfer to cancer cells for long -term expression and secretion of antiangiogenic factors may, therefore, represent an effective strategy to inhibit the growth of adjacent endothelial cells. Accordingly, BAEC cells were cocultured with lentivirus -transduced T24 cells in a dual -chamber assay using Transwell inserts (Fig 4A ) . Coculture of endothelial cells with either T24Ang or T24End resulted in significant inhibition of endothelial cell proliferation (P < .05 with T24Ang coculture, P <.005 with T24End coculture; Figure 4B ) , associated with an increased percentage of endothelial cells in G 0 /G 1 phase ( P <.05 with T24Ang coculture; Table 4 ) and decreased percentage in the S phase ( P< .05 with T24Ang coculture, P< .1 with T24End coculture; Table 4) . These data thus demonstrate the ability of antiangiogenic lentiviral vectors to mediate antiproliferative effects on endothelial cells indirectly via paracrine secretion from transduced tumor cells.
DISCUSSION
Lentivirus vectors are capable of infecting nondividing cells, and the vector genome can permanently integrate into the target cell. In the present study, recombinant lentivirus vectors expressing secreted forms of angiostatin and endostatin were constructed and tested for their antiangiogenic effects. A third -generation self -inactivating lentivirus vector was employed, in which the U3 region of the 3 0 LTR including the TATA box has been deleted, abolishing LTR promoter activity. 22 During reverse transcription, this deletion is transferred to the 5 0 LTR of the proviral DNA, thereby reducing the extent of overlap homology, and so the risk of generating replication -competent revertants is minimized. Moreover, interference between the LTR and the internal promoter is prevented, enhancing the levels of transgene expression. When pseudotyped with the VSV-G envelope, these lentivirus vectors efficiently transduced cancer cells that were resistant to adenovirus infection, resulting in expression and secretion of angiostatin and endostatin at levels sufficient to achieve significant inhibition of cocultured endothelial cells. To our knowledge, this represents the first report of lentivirus -based vectors encoding these antiangiogenic factors.
Although there have been previous reports of simpler MLV-based retrovirus vectors for gene delivery of angiostatin or endostatin, 12, 29 these vectors require active cell division to achieve nuclear entry and integration, whereas our results suggest that lentivirus vectors have a comparative advantage in transducing slowly dividing cells such as endothelial cells. This advantage would presumably also be apparent in normal tissues as well as tumors in vivo, which generally show reduced rates of cell division compared to transformed cell lines in culture.
However, VSV-G -pseudotyped lentivirus vectors were found to show a reduced efficiency of transduction to endothelial cells, compared to epithelial carcinoma cells. When the equivalent adenovirus vectors expressing GFP, angiostatin, and endostatin, were constructed and tested, reduced transduction efficiency of these vectors on endothelial cells was observed as well. In the case of adenovirus vectors, the most likely reason for this reduced transduction efficiency is the lack of CAR on the surface of endothelial cells, which normally mediates primary binding of the adenovirus fiber knob to target cells. 30 Thus, adenovirus binding and entry to these cells is dependent on the lower affinity interaction between the adenovirus penton and cell surface integrins, 31 presumably v3 or v5 integrins in the case of endothelial cells. 32, 33 However, it is less clear why VSV-G -pseudotyped lentivirus vectors also showed reduced efficiency of transduction to endothelial cells. Although blocks to lentivirus entry can occur at any step Using Transwell chambers, BAEC cells were cocultured with T24 cells that had previously been infected with recombinant lentivirus vectors. The values represent the percentage of BAEC cells in G 0 / G 1 phase and S phase after coculture with, respectively, Sin -Ang ( BAEC + T24Ang ) , Sin -End ( BAEC + T24End ) , and control vector Sin -GFP ( BAEC + T24GFP ) . Asterisks indicate significant P values compared to coculture with the BAEC + T24GFP control; *P < .1; **P < .05.
Cancer Gene Therapy, Vol 8, No 11, 2001 in the viral entry process, including cell surface binding, virus -cell membrane fusion, reverse transcription, and nuclear translocation, the initial step of cell surface binding by the VSV-G envelope has not usually been considered to be a rate -limiting factor. The VSV-G envelope is thought to bind to cell membrane phospholipids such as phosphatidylserine, 27, 28 and VSV-G -pseudotyped vectors have been shown to achieve transduction of a wide variety of cell types. 19,34 -36 Nevertheless, as phosphatidylserine is normally present in limited quantities in the outer leaflet of the lipid bilayer surrounding most cells, 37 and, in fact, the presence of easily detectable quantities of this phospholipid in the outer leaflet is commonly used as the basis for assays of cell apoptosis. 38, 39 Thus, it is possible that the quantity or distribution of putative phospholipid receptors for VSV-G may differ between cells of endothelial and epithelial origin, 40, 41 or even during different phases of endothelial cell growth, 42 and that this might contribute to the relative resistance of endothelial cells to direct transduction by lentivirus vectors. A similar process has been suggested to account for increasing susceptibility of aging red blood cell membranes to VSV fusion. 43 Furthermore, incubating endothelial cells with lentivirus vectors at increasing MOI was observed to result in the appearance of significant vector -associated cytotoxicity. This toxicity markedly affected cell proliferation and viability, with up to 50% inhibition of BAEC cells even with the Sin -GFP lentivirus control vector at MOIs as low as 1. This cytotoxicity was presumably associated with the lentivirus vector itself, and not simply due to overexpression of GFP, as no such cytotoxic effects were observed in the endothelial cells with comparable levels of GFP transduction using adenovirus vectors. One potential cause of lentivirus vector -associated toxicity is the presence of excess amounts of soluble VSV-G protein contaminating the transfected 293 cell supernatant medium, which is harvested to obtain the vector preparation. This possibility was supported by the fact that similar toxicities were observed after incubation of endothelial cells with conditioned medium from cells transfected with VSV-G alone. VSV-G protein is highly fusogenic and can result in cytotoxic effects that vary according to the type of cell exposed. Certainly in this instance, BAEC cells appeared to be more susceptible than HUV-EC -C cells, although the latter eventually showed similar effects at higher MOI. However, this problem may be overcome by further purification of the vector preparation to remove excess free VSV-G protein.
Whereas vector-associated toxicity limited the efficacy of direct lentivirus -mediated gene transfer to endothelial cells, adenovirus vectors showed no such toxicity and significant inhibition of endothelial cell growth was achieved by endogenous expression of angiostatin and endostatin. Upon comparing these two antiangiogenic adenovirus vectors, Ad -End appeared to inhibit proliferation of both BAEC and HUV-EC -C cells at lower MOIs than Ad -Ang; hence, endostatin might be the more effective agent when delivered in this context. Recent studies have also reported that endostatin is more potent than angiostatin, both in studies performed in vitro using AAV vectors, 14 and in vivo experiments comparing liposome-mediated gene transfer of angiostatin and endostatin. 44 Adenovirus vectors have the advantage of high production titers and efficient gene delivery in vivo. However, as adenoviral vectors do not integrate into the host genome, transgene expression is transient, and this is further limited by immune responses against adenovirus gene products, which are expressed at low levels in the transduced cells despite deletion of the E1 regulatory gene in conventional vectors. 45 As a result, cytotoxic T lymphocytes rapidly eliminate adenovirus -transduced cells in vivo, and once sensitized, neutralizing antibody responses also develop, which usually preclude repeat administration by the same vector. 45 Because antiangiogenic strategies are not directly cytotoxic but rather cytostatic in nature, and small nests of tumor cells can still maintain viability in the absence of neovasculature by simple diffusion of nutrients, the loss of antiangiogenic gene expression would result in rapid regrowth of dormant nests of tumor cells as has been demonstrated after transient endostatin expression from adenovirus vectors in animal models of cancer. 16 Thus, for long -term tumor growth inhibition, repeat administration of antiangiogenic adenovirus vectors would be necessary, which would then necessitate immunosuppressive strategies.
As in the case of endothelial cells, the efficiency of adenovirus -mediated gene delivery to T24 bladder cancer cells, which have lost expression of the primary adenovirus receptor CAR, 26 was reduced 100-fold compared to CARpositive HeLa cells. This may represent a significant issue with regard to the use of adenovirus vectors for clinical cancer gene therapy, as > 50% of tumor tissues from patients with early -stage bladder cancer show loss of CAR expression, progressing to complete loss of CAR as well as v3 and v5 integrin expression in all cases of poorly differentiated late -stage bladder cancers examined (B. Bochner et al, manuscript in preparation ). In contrast, VSV-G -pseudotyped lentivirus vectors transduced T24 cells and HeLa cells with equal efficiency, resulting in the long -term expression and secretion of angiostatin and endostatin from these cells at levels high enough to achieve significant growth inhibition of adjacent endothelial cells in a dual -chamber coculture assay.
Based on its ability to integrate into the genome, and hence its potential to achieve long -term stable expression and to maintain therapeutic levels of secreted peptides, lentivirus -mediated gene delivery of antiangiogenic factors thus appears to be a promising approach for cancer gene therapy. Here we have demonstrated the use of recombinant lentivirus vectors for stable transduction of cancer cells to achieve paracrine secretion of angiostatin and endostatin for local suppression of angiogenesis. The ability of lentivirus vectors to infect nondividing cells, due to the presence of karyophilic sequences that enable active transport of the lentiviral preintegration complex into the nucleus, may also prove advantageous for introduction of these transgenes into normal parenchymal tissue. This could serve as an endogenous source of constitutively secreted antiangiogenic factors, an approach that may offer the potential for prevention of distant metastases and local recurrences of malignancies after surgical removal of the primary tumors.
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